New Form 8-K - CORE MOLDING TECHNOLOGIES INC Filed: 2025-08-05 AccNo: 0001026655-25-000069 Size: 397 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
Core Molding Technologies Announces 2026 Leadership Transition
Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center
Vivani Medical Announces Rapid Advancement of NPM-139, a Novel Semaglutide Implant, Following Positive Weight Loss Data from an Ongoing Preclinical Study of NPM-139 and Promising Results from the LIBERATE-1 Phase 1 Clinical Study of NPM-115
Butterfly Network, Inc. - Butterfly Network Advances AI-Powered Aortic Valve and Aorta Screening with New Research and Training Tools
Curis Provides Second Quarter 2025 Business Update
SenesTech Announces Warrant Exercise for $6.3 Million in Gross Proceeds